Rapamycin treatment ameliorates HLA-B27-mediated gut inflammation and alters the microbiome in experimental spondyloarthritis
ObjectiveTo determine whether rapamycin affects HLA-B27-mediated gut inflammation in experimental spondyloarthritis (SpA).MethodsHLA-B27/human β2-microglobulin transgenic (B27-Tg) rats with gut inflammation were treated with rapamycin (1.5 mg/kg intraperitoneally, 3 times a week) or vehicle for 5 we...
Na minha lista:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2026-03-01
|
| Serier: | Frontiers in Immunology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1755132/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
